Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Ziopharm Oncology IN (ZIOP)

Ziopharm Oncology IN (ZIOP)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Ziopharm Oncology IN ONE FIRST AVENUE PARRIS BUILDING 34 BOSTON MA 02129 USA

P: 617-259-1970 F: 617-241-2855

Description:

ZIOPHARM Oncology, Inc. is a biopharmaceutical company engaged in the development and commercialization of a diverse, risk-sensitive portfolio of in-licensed cancer drugs to address unmet medical needs. The Company applies new insights from molecular and cancer biology to understand the efficacy and safety limitations of approved and developmental cancer therapies and identifies proprietary and related molecules for better patient treatment.

Key Statistics

Overview:

Market Capitalization, $K 711,430
Shares Outstanding, K 214,286
Annual Sales, $ 0 K
Annual Net Income, $ -117,800 K
60-Month Beta 2.48
% of Insider Shareholders 2.30%
% of Institutional Shareholders 46.13%
Float, K 209,357
% Float 97.70%

Growth:

1-Year Return -46.62%
3-Year Return -39.75%
5-Year Return -65.60%
5-Year Revenue Growth -100.00%
5-Year Earnings Growth 20.93%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.09 on 08/06/20
Next Earnings Date N/A
Earnings Per Share ttm -0.25
EPS Growth vs. Prev Qtr 0.00%
EPS Growth vs. Prev Year 0.00%
Annual Dividend Rate, $ 0.00
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00

ZIOP Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward -6.22
Price/Earnings to Growth N/A
Return-on-Equity % -51.95%
Return-on-Assets % -46.59%
Profit Margin % N/A
Net Margin % N/A
Debt/Equity 0.01
Price/Sales N/A
Price/Cash Flow N/A
Price/Book 3.80
Book Value/Share 0.00
Interest Coverage 0.00
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar